RNU6-1208P

Across TCGA pan-cancer cohorts, RNU6-1208P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RNU6-1208P data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RNU6-1208P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1208P expression acts as an unfavorable survival marker, although some lineages such as SARC and ESCA show a favorable association.

LUSC, SKCM, and PAAD are the cancer types where RNU6-1208P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	II,III,IV	0.142	0.415	.007	72	view →
SKCM	OS	Tertile	II,III,IV	0.447	0.748	<.001	63	view →
PAAD	DFS	Tertile	All	0.098	0.505	.002	36	view →
KIRP	DFS	Tertile	IV	0.162	0.546	.009	36	view →
UCEC	OS	Tertile	All	0.805	0.930	.019	30	view →
READ	OS	Tertile	All	0.205	0.693	.015	27	view →
OV	DFS	Quartile	IV	0.281	0.504	.017	18	view →
COAD	DFS	Tertile	III,IV	0.165	0.622	.012	18	view →
TGCT	DFS	Tertile	All	0.543	0.822	.005	18	view →
HNSC	DFS	Tertile	II,III,IV	0.283	0.562	.045	9	view →
SARC	OS	Tertile	All	0.922	0.726	.021	9	view →
ESCA	DFS	Median	III,IV	0.403	0.247	.039	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RNU6-1208P–LUSC (DFS)

Open the LUSC breakdown →